Sanofi has announced it will extend its partnership with technology company Medidata to expedite the development of new therapies.  The new agreement will take advantage of the Medidata Patient, Data, and Study Experiences, building on both organisations’ aim to boost innovation in studies, speed new therapies to market, and promote health outcomes for people globally.  The […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!